Menarini Group
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Menarini Group sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Menarini Group: 9 sponsored US clinical trials, none currently recruiting.
Menarini Group sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 2 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Colic, with 1 trials.
Top-decile sponsor footprint
Menarini Group ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
NCT04495621
MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
NCT03767335
MEN1703 (SEL24) in Participants With Acute Myeloid Leukemia
NCT03008187
Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee
NCT02205814
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02107196
52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02120027
Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance
NCT01532518
A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants
NCT00655083
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
NCT00418574
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
How the Menarini Group early-phase archive is shaped
9 indexed studies, none listed as recruiting (0% open); 7 completed (78%).
Phase mix: 2 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Colic (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Menarini Group: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Menarini Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Menarini Group page
9 registered trials is a research-attention snapshot, not an endorsement of Menarini Group or any single study.
- None of Menarini Group's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Colic is the condition Menarini Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Colic trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Menarini Group pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.